From Cancer Fighter to Health Revolutionary: The Story of Dr. Anne Le
Before founding GiganTest and creating the HealthieOne platform, Dr. Anne Le spent over a decade as a professor and researcher at the Johns Hopkins University School of Medicine. Her groundbreaking work in metabolomics led to the discovery that cancer cells can survive and replicate using alternative metabolic pathways beyond glucose.
Featured in BioBuzz, this article details her transition from leading a world-class academic core facility to launching her own proprietary clinical laboratory. Driven by the mission to bring hospital-grade, metabolomics with mass spectrometry analysis out of elite research silos and directly to consumers, her work bridges the gap between complex disease research and preventative health tracking.
The Johns Hopkins Metabolomics Infrastructure
The technology powering HealthieOne was not built in a Silicon Valley garage. It is born directly from the rigorous standards of the Johns Hopkins Institute for Clinical and Translational Research (ICTR). Dr. Anne Le directed the Metabolomics Core Facility at Johns Hopkins, providing essential molecular analysis for global medical research.
This background ensures that the processes used at GiganTest's CLIA & CAP accredited lab meet the exact same scientific rigor demanded by the world's leading medical researchers when studying complex metabolic diseases.
Johns Hopkins ICTR Metabolomics Lab
GiganTest: The Proprietary Lab Behind HealthieOne
While most direct-to-consumer health companies operate as digital middlemen outsourcing testing to legacy labs, HealthieOne is directly powered by its parent company: GiganTest.
GiganTest specializes in advanced metabolomics with mass spectrometry and lipidomics. This proprietary clinical infrastructure is what allows HealthieOne to extract over 250 highly specific biomarkers from a single 1mL blood sample, bypassing the need for the 10-15 vials of blood required by legacy testing methodologies.
The laboratory is overseen by Dr. James Ritchie, PhD (Lab Director and Emeritus Professor at Emory University) and strictly adheres to CLIA & CAP accreditations, ensuring all data stays within the United States.
Explore a Complete 250+ Biomarker Sample Report
Seeing is believing. Traditional lab results are often confusing, monochrome PDFs sent with no context. HealthieOne maps your 250+ biomarkers into a secure, highly interactive dashboard that allows you to clearly identify areas of optimization.
Here is a fully anonymized, complete patient sample report available for public viewing. You can explore the depth of the metabolomics analysis, covering everything from complex cardiovascular indicators and hormone balances to unique cellular energy metrics that standard labs simply cannot test for.
Meet the Team
The foundation of HealthieOne is their team of dedicated medical doctors (MDs), PhD scientists, and clinical laboratory professionals who possess decades of combined experience in advanced research and patient care.
Dr. Anne Le, a former Johns Hopkins professor and Metabolomics Core Director, pioneered the metabolomics technology and founded Gigantest to make it available to everyone. By combining traditional blood testing technologies and Gigantest’s proprietary next-level metabolomics, the scientists at Gigantest have developed a series of novel health tests that are poised to revolutionize health monitoring.
Their team has spent years managing CAP-accredited, CLIA-certified clinical testing laboratories. By combining deep medical expertise with cutting-edge metabolomics, they work together to ensure that every patient receives scientifically rigorous, highly personalized, and actionable blood analysis.
Rather than providing simple numbers on a page, their clinical experts review and discuss the complex biomarkers with patients, explaining how different metabolic pathways interact to shape overall longevity and health.
Collaborative clinical metabolomics review